Project
Illumina Body Map 2
Navigation
Downloads
Results for EN1_ESX1_GBX1
Z-value: 1.12
Motif logo
Transcription factors associated with EN1_ESX1_GBX1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
EN1
|
ENSG00000163064.6 | engrailed homeobox 1 |
|
ESX1
|
ENSG00000123576.5 | ESX homeobox 1 |
|
GBX1
|
ENSG00000164900.4 | gastrulation brain homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ESX1 | hg19_v2_chrX_-_103499602_103499617 | 0.23 | 2.1e-01 | Click! |
| GBX1 | hg19_v2_chr7_-_150864635_150864785 | 0.19 | 2.9e-01 | Click! |
| EN1 | hg19_v2_chr2_-_119605253_119605264 | 0.03 | 8.5e-01 | Click! |
Activity profile of EN1_ESX1_GBX1 motif
Sorted Z-values of EN1_ESX1_GBX1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_+_160160346 | 4.91 |
ENST00000368078.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
| chr1_+_160160283 | 4.90 |
ENST00000368079.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
| chr4_-_138453606 | 4.35 |
ENST00000412923.2
ENST00000344876.4 ENST00000507846.1 ENST00000510305.1 |
PCDH18
|
protocadherin 18 |
| chr9_-_95166976 | 3.79 |
ENST00000447356.1
|
OGN
|
osteoglycin |
| chr3_+_115342349 | 3.57 |
ENST00000393780.3
|
GAP43
|
growth associated protein 43 |
| chr9_-_95166884 | 3.54 |
ENST00000375561.5
|
OGN
|
osteoglycin |
| chr15_-_37393406 | 3.51 |
ENST00000338564.5
ENST00000558313.1 ENST00000340545.5 |
MEIS2
|
Meis homeobox 2 |
| chr10_-_93392811 | 3.24 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
| chr1_-_234667504 | 3.19 |
ENST00000421207.1
ENST00000435574.1 |
RP5-855F14.1
|
RP5-855F14.1 |
| chr13_-_36788718 | 3.02 |
ENST00000317764.6
ENST00000379881.3 |
SOHLH2
|
spermatogenesis and oogenesis specific basic helix-loop-helix 2 |
| chr3_+_2933893 | 2.97 |
ENST00000397459.2
|
CNTN4
|
contactin 4 |
| chr9_-_95166841 | 2.95 |
ENST00000262551.4
|
OGN
|
osteoglycin |
| chr3_-_187009646 | 2.94 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr4_-_138453559 | 2.92 |
ENST00000511115.1
|
PCDH18
|
protocadherin 18 |
| chr13_+_110958124 | 2.70 |
ENST00000400163.2
|
COL4A2
|
collagen, type IV, alpha 2 |
| chr7_-_137028534 | 2.69 |
ENST00000348225.2
|
PTN
|
pleiotrophin |
| chr13_-_86373536 | 2.64 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
| chr11_-_40315640 | 2.58 |
ENST00000278198.2
|
LRRC4C
|
leucine rich repeat containing 4C |
| chr7_-_137028498 | 2.54 |
ENST00000393083.2
|
PTN
|
pleiotrophin |
| chr12_-_6233828 | 2.53 |
ENST00000572068.1
ENST00000261405.5 |
VWF
|
von Willebrand factor |
| chr14_-_38064198 | 2.49 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
| chr17_+_59489112 | 2.46 |
ENST00000335108.2
|
C17orf82
|
chromosome 17 open reading frame 82 |
| chr10_+_5005598 | 2.45 |
ENST00000442997.1
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
| chr11_-_101000445 | 2.38 |
ENST00000534013.1
|
PGR
|
progesterone receptor |
| chr16_-_29910853 | 2.38 |
ENST00000308713.5
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
| chr7_-_14029283 | 2.36 |
ENST00000433547.1
ENST00000405192.2 |
ETV1
|
ets variant 1 |
| chr8_+_98900132 | 2.30 |
ENST00000520016.1
|
MATN2
|
matrilin 2 |
| chr11_-_118023490 | 2.25 |
ENST00000324727.4
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta subunit |
| chr11_-_111794446 | 2.25 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
| chr8_+_98881268 | 2.18 |
ENST00000254898.5
ENST00000524308.1 ENST00000522025.2 |
MATN2
|
matrilin 2 |
| chr3_+_120626919 | 2.15 |
ENST00000273666.6
ENST00000471454.1 ENST00000472879.1 ENST00000497029.1 ENST00000492541.1 |
STXBP5L
|
syntaxin binding protein 5-like |
| chr1_-_190446759 | 2.12 |
ENST00000367462.3
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
| chr4_+_70796784 | 2.11 |
ENST00000246891.4
ENST00000444405.3 |
CSN1S1
|
casein alpha s1 |
| chr12_-_16760021 | 2.10 |
ENST00000540445.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr8_+_121137333 | 2.09 |
ENST00000309791.4
ENST00000297848.3 ENST00000247781.3 |
COL14A1
|
collagen, type XIV, alpha 1 |
| chr12_-_16759711 | 2.06 |
ENST00000447609.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr7_-_14029515 | 2.05 |
ENST00000430479.1
ENST00000405218.2 ENST00000343495.5 |
ETV1
|
ets variant 1 |
| chr12_-_28123206 | 2.03 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr17_-_38821373 | 2.01 |
ENST00000394052.3
|
KRT222
|
keratin 222 |
| chr8_+_105235572 | 2.01 |
ENST00000523362.1
|
RIMS2
|
regulating synaptic membrane exocytosis 2 |
| chr3_-_112360116 | 2.00 |
ENST00000206423.3
ENST00000439685.2 |
CCDC80
|
coiled-coil domain containing 80 |
| chrX_-_100129128 | 2.00 |
ENST00000372960.4
ENST00000372964.1 ENST00000217885.5 |
NOX1
|
NADPH oxidase 1 |
| chr12_-_22063787 | 1.96 |
ENST00000544039.1
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
| chr10_-_50970382 | 1.96 |
ENST00000419399.1
ENST00000432695.1 |
OGDHL
|
oxoglutarate dehydrogenase-like |
| chr19_-_51522955 | 1.93 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
| chr4_-_105416039 | 1.88 |
ENST00000394767.2
|
CXXC4
|
CXXC finger protein 4 |
| chr10_-_50970322 | 1.88 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
| chrX_-_110507098 | 1.88 |
ENST00000541758.1
|
CAPN6
|
calpain 6 |
| chr4_+_169013666 | 1.87 |
ENST00000359299.3
|
ANXA10
|
annexin A10 |
| chr1_+_160370344 | 1.86 |
ENST00000368061.2
|
VANGL2
|
VANGL planar cell polarity protein 2 |
| chr4_+_77356248 | 1.85 |
ENST00000296043.6
|
SHROOM3
|
shroom family member 3 |
| chr13_-_28545276 | 1.83 |
ENST00000381020.7
|
CDX2
|
caudal type homeobox 2 |
| chr12_+_41831485 | 1.81 |
ENST00000539469.2
ENST00000298919.7 |
PDZRN4
|
PDZ domain containing ring finger 4 |
| chr9_-_117267717 | 1.81 |
ENST00000374057.3
|
DFNB31
|
deafness, autosomal recessive 31 |
| chr4_-_46126093 | 1.80 |
ENST00000295452.4
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
| chr1_-_36916011 | 1.75 |
ENST00000356637.5
ENST00000354267.3 ENST00000235532.5 |
OSCP1
|
organic solute carrier partner 1 |
| chr5_-_115890554 | 1.74 |
ENST00000509665.1
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
| chr3_+_173116225 | 1.74 |
ENST00000457714.1
|
NLGN1
|
neuroligin 1 |
| chr4_-_174451370 | 1.73 |
ENST00000359562.4
|
HAND2
|
heart and neural crest derivatives expressed 2 |
| chr12_+_26348246 | 1.72 |
ENST00000422622.2
|
SSPN
|
sarcospan |
| chr2_-_224467093 | 1.72 |
ENST00000305409.2
|
SCG2
|
secretogranin II |
| chr5_+_53751445 | 1.71 |
ENST00000302005.1
|
HSPB3
|
heat shock 27kDa protein 3 |
| chr12_-_88974236 | 1.71 |
ENST00000228280.5
ENST00000552044.1 ENST00000357116.4 |
KITLG
|
KIT ligand |
| chr12_+_16500571 | 1.69 |
ENST00000543076.1
ENST00000396210.3 |
MGST1
|
microsomal glutathione S-transferase 1 |
| chr3_+_111717511 | 1.68 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
| chr12_-_16759440 | 1.67 |
ENST00000537304.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr5_+_52776228 | 1.66 |
ENST00000256759.3
|
FST
|
follistatin |
| chr12_-_28122980 | 1.65 |
ENST00000395868.3
ENST00000534890.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr11_-_26593649 | 1.65 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
| chr16_-_55866997 | 1.62 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
| chrX_-_13835147 | 1.62 |
ENST00000493677.1
ENST00000355135.2 |
GPM6B
|
glycoprotein M6B |
| chr6_-_49681235 | 1.61 |
ENST00000339139.4
|
CRISP2
|
cysteine-rich secretory protein 2 |
| chr3_-_160823158 | 1.59 |
ENST00000392779.2
ENST00000392780.1 ENST00000494173.1 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
| chr18_-_71959159 | 1.59 |
ENST00000494131.2
ENST00000397914.4 ENST00000340533.4 |
CYB5A
|
cytochrome b5 type A (microsomal) |
| chr5_+_52776449 | 1.58 |
ENST00000396947.3
|
FST
|
follistatin |
| chr7_-_73038822 | 1.58 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
| chr1_+_209878182 | 1.58 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chr6_-_127780510 | 1.57 |
ENST00000487331.2
ENST00000483725.3 |
KIAA0408
|
KIAA0408 |
| chr12_-_23737534 | 1.54 |
ENST00000396007.2
|
SOX5
|
SRY (sex determining region Y)-box 5 |
| chr12_-_16760195 | 1.52 |
ENST00000546281.1
ENST00000537757.1 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr3_+_156544057 | 1.52 |
ENST00000498839.1
ENST00000470811.1 ENST00000356539.4 ENST00000483177.1 ENST00000477399.1 ENST00000491763.1 |
LEKR1
|
leucine, glutamate and lysine rich 1 |
| chr3_-_180397256 | 1.49 |
ENST00000442201.2
|
CCDC39
|
coiled-coil domain containing 39 |
| chr5_-_147286065 | 1.49 |
ENST00000318315.4
ENST00000515291.1 |
C5orf46
|
chromosome 5 open reading frame 46 |
| chr7_-_73038867 | 1.48 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
| chr12_+_16500037 | 1.45 |
ENST00000536371.1
ENST00000010404.2 |
MGST1
|
microsomal glutathione S-transferase 1 |
| chrX_-_18690210 | 1.45 |
ENST00000379984.3
|
RS1
|
retinoschisin 1 |
| chr1_-_36916066 | 1.44 |
ENST00000315643.9
|
OSCP1
|
organic solute carrier partner 1 |
| chr3_-_160823040 | 1.44 |
ENST00000484127.1
ENST00000492353.1 ENST00000473142.1 ENST00000468268.1 ENST00000460353.1 ENST00000320474.4 ENST00000392781.2 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
| chr3_+_111717600 | 1.42 |
ENST00000273368.4
|
TAGLN3
|
transgelin 3 |
| chr11_-_26593779 | 1.42 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
| chr8_+_50824233 | 1.41 |
ENST00000522124.1
|
SNTG1
|
syntrophin, gamma 1 |
| chr17_-_64225508 | 1.40 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr7_-_107642348 | 1.39 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
| chr11_+_24518723 | 1.38 |
ENST00000336930.6
ENST00000529015.1 ENST00000533227.1 |
LUZP2
|
leucine zipper protein 2 |
| chrX_-_73051037 | 1.38 |
ENST00000445814.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
| chr12_+_78359999 | 1.38 |
ENST00000550503.1
|
NAV3
|
neuron navigator 3 |
| chr19_-_47137942 | 1.37 |
ENST00000300873.4
|
GNG8
|
guanine nucleotide binding protein (G protein), gamma 8 |
| chr8_-_86290333 | 1.37 |
ENST00000521846.1
ENST00000523022.1 ENST00000524324.1 ENST00000519991.1 ENST00000520663.1 ENST00000517590.1 ENST00000522579.1 ENST00000522814.1 ENST00000522662.1 ENST00000523858.1 ENST00000519129.1 |
CA1
|
carbonic anhydrase I |
| chr2_+_159825143 | 1.36 |
ENST00000454300.1
ENST00000263635.6 |
TANC1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
| chr2_+_158114051 | 1.33 |
ENST00000259056.4
|
GALNT5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
| chr14_+_104182061 | 1.31 |
ENST00000216602.6
|
ZFYVE21
|
zinc finger, FYVE domain containing 21 |
| chr12_+_26348429 | 1.31 |
ENST00000242729.2
|
SSPN
|
sarcospan |
| chrX_-_130423200 | 1.29 |
ENST00000361420.3
|
IGSF1
|
immunoglobulin superfamily, member 1 |
| chr5_+_140557371 | 1.28 |
ENST00000239444.2
|
PCDHB8
|
protocadherin beta 8 |
| chr12_+_16500599 | 1.26 |
ENST00000535309.1
ENST00000540056.1 ENST00000396209.1 ENST00000540126.1 |
MGST1
|
microsomal glutathione S-transferase 1 |
| chr14_+_104182105 | 1.26 |
ENST00000311141.2
|
ZFYVE21
|
zinc finger, FYVE domain containing 21 |
| chr3_-_151034734 | 1.26 |
ENST00000260843.4
|
GPR87
|
G protein-coupled receptor 87 |
| chr17_-_46716647 | 1.25 |
ENST00000608940.1
|
RP11-357H14.17
|
RP11-357H14.17 |
| chr3_-_187009798 | 1.24 |
ENST00000337774.5
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr4_-_186570679 | 1.24 |
ENST00000451974.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr2_+_217524323 | 1.23 |
ENST00000456764.1
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
| chr2_+_234826016 | 1.23 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
| chr8_-_1922789 | 1.23 |
ENST00000521498.1
|
RP11-439C15.4
|
RP11-439C15.4 |
| chr11_+_60383204 | 1.23 |
ENST00000412599.1
ENST00000320202.4 |
LINC00301
|
long intergenic non-protein coding RNA 301 |
| chr3_-_74570291 | 1.22 |
ENST00000263665.6
|
CNTN3
|
contactin 3 (plasmacytoma associated) |
| chr1_-_36915880 | 1.22 |
ENST00000445843.3
|
OSCP1
|
organic solute carrier partner 1 |
| chr8_-_18744528 | 1.21 |
ENST00000523619.1
|
PSD3
|
pleckstrin and Sec7 domain containing 3 |
| chr3_-_123339343 | 1.21 |
ENST00000578202.1
|
MYLK
|
myosin light chain kinase |
| chr3_+_111718036 | 1.20 |
ENST00000455401.2
|
TAGLN3
|
transgelin 3 |
| chr3_+_174158732 | 1.20 |
ENST00000434257.1
|
NAALADL2
|
N-acetylated alpha-linked acidic dipeptidase-like 2 |
| chr2_-_188419078 | 1.19 |
ENST00000437725.1
ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
| chr3_+_155860751 | 1.18 |
ENST00000471742.1
|
KCNAB1
|
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
| chr1_-_22215192 | 1.18 |
ENST00000374673.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr15_+_63188009 | 1.16 |
ENST00000557900.1
|
RP11-1069G10.2
|
RP11-1069G10.2 |
| chr3_-_195538728 | 1.16 |
ENST00000349607.4
ENST00000346145.4 |
MUC4
|
mucin 4, cell surface associated |
| chr4_-_186696425 | 1.16 |
ENST00000430503.1
ENST00000319454.6 ENST00000450341.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr3_-_100565249 | 1.16 |
ENST00000495591.1
ENST00000383691.4 ENST00000466947.1 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
| chrX_+_99839799 | 1.14 |
ENST00000373031.4
|
TNMD
|
tenomodulin |
| chr15_+_54305101 | 1.14 |
ENST00000260323.11
ENST00000545554.1 ENST00000537900.1 |
UNC13C
|
unc-13 homolog C (C. elegans) |
| chr11_-_26593677 | 1.14 |
ENST00000527569.1
|
MUC15
|
mucin 15, cell surface associated |
| chr5_+_31193847 | 1.12 |
ENST00000514738.1
ENST00000265071.2 |
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney) |
| chr4_+_134070439 | 1.11 |
ENST00000264360.5
|
PCDH10
|
protocadherin 10 |
| chr18_-_31803435 | 1.10 |
ENST00000589544.1
ENST00000269185.4 ENST00000261592.5 |
NOL4
|
nucleolar protein 4 |
| chr1_+_196788887 | 1.10 |
ENST00000320493.5
ENST00000367424.4 ENST00000367421.3 |
CFHR1
CFHR2
|
complement factor H-related 1 complement factor H-related 2 |
| chr6_-_167040693 | 1.10 |
ENST00000366863.2
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
| chr18_+_76740189 | 1.09 |
ENST00000537592.2
ENST00000575389.2 |
SALL3
|
spalt-like transcription factor 3 |
| chr7_-_14028488 | 1.09 |
ENST00000405358.4
|
ETV1
|
ets variant 1 |
| chr8_+_92261516 | 1.08 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
| chr12_+_20963632 | 1.08 |
ENST00000540853.1
ENST00000261196.2 |
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
| chr14_+_101359265 | 1.08 |
ENST00000599197.1
|
AL117190.3
|
Esophagus cancer-related gene-2 interaction susceptibility protein; Uncharacterized protein |
| chr2_+_210636697 | 1.08 |
ENST00000439458.1
ENST00000272845.6 |
UNC80
|
unc-80 homolog (C. elegans) |
| chrX_-_100129320 | 1.07 |
ENST00000372966.3
|
NOX1
|
NADPH oxidase 1 |
| chr5_-_160279207 | 1.06 |
ENST00000327245.5
|
ATP10B
|
ATPase, class V, type 10B |
| chr4_+_150999418 | 1.05 |
ENST00000296550.7
|
DCLK2
|
doublecortin-like kinase 2 |
| chr7_+_73245193 | 1.05 |
ENST00000340958.2
|
CLDN4
|
claudin 4 |
| chr5_+_125758813 | 1.04 |
ENST00000285689.3
ENST00000515200.1 |
GRAMD3
|
GRAM domain containing 3 |
| chr5_-_82969405 | 1.04 |
ENST00000510978.1
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1 |
| chr3_+_149191723 | 1.03 |
ENST00000305354.4
|
TM4SF4
|
transmembrane 4 L six family member 4 |
| chr8_-_101661887 | 1.02 |
ENST00000311812.2
|
SNX31
|
sorting nexin 31 |
| chr21_+_17442799 | 1.02 |
ENST00000602580.1
ENST00000458468.1 ENST00000602935.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
| chr1_+_81771806 | 1.02 |
ENST00000370721.1
ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2
|
latrophilin 2 |
| chr10_-_5046042 | 1.01 |
ENST00000421196.3
ENST00000455190.1 |
AKR1C2
|
aldo-keto reductase family 1, member C2 |
| chr12_+_56473939 | 1.01 |
ENST00000450146.2
|
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
| chr1_+_152943122 | 1.00 |
ENST00000328051.2
|
SPRR4
|
small proline-rich protein 4 |
| chr3_-_195538760 | 0.99 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
| chr10_+_18629628 | 0.99 |
ENST00000377329.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr4_-_66536057 | 0.99 |
ENST00000273854.3
|
EPHA5
|
EPH receptor A5 |
| chr10_-_128110441 | 0.98 |
ENST00000456514.1
|
LINC00601
|
long intergenic non-protein coding RNA 601 |
| chr18_-_48351743 | 0.97 |
ENST00000588444.1
ENST00000256425.2 ENST00000428869.2 |
MRO
|
maestro |
| chr6_+_153552455 | 0.97 |
ENST00000392385.2
|
AL590867.1
|
Uncharacterized protein; cDNA FLJ59044, highly similar to LINE-1 reverse transcriptase homolog |
| chr11_-_118023594 | 0.96 |
ENST00000529878.1
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta subunit |
| chr22_-_28490123 | 0.96 |
ENST00000442232.1
|
TTC28
|
tetratricopeptide repeat domain 28 |
| chr11_+_94706973 | 0.96 |
ENST00000536741.1
|
KDM4D
|
lysine (K)-specific demethylase 4D |
| chr5_+_125758865 | 0.95 |
ENST00000542322.1
ENST00000544396.1 |
GRAMD3
|
GRAM domain containing 3 |
| chr1_+_175036966 | 0.94 |
ENST00000239462.4
|
TNN
|
tenascin N |
| chr3_-_187009468 | 0.94 |
ENST00000425937.1
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr20_+_43849941 | 0.94 |
ENST00000372769.3
|
SEMG2
|
semenogelin II |
| chr18_+_32173276 | 0.94 |
ENST00000591816.1
ENST00000588125.1 ENST00000598334.1 ENST00000588684.1 ENST00000554864.3 ENST00000399121.5 ENST00000595022.1 ENST00000269190.7 ENST00000399097.3 |
DTNA
|
dystrobrevin, alpha |
| chr12_+_20963647 | 0.93 |
ENST00000381545.3
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
| chr12_+_52056548 | 0.93 |
ENST00000545061.1
ENST00000355133.3 |
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
| chr12_+_57157100 | 0.93 |
ENST00000322165.1
|
HSD17B6
|
hydroxysteroid (17-beta) dehydrogenase 6 |
| chr3_-_164796269 | 0.90 |
ENST00000264382.3
|
SI
|
sucrase-isomaltase (alpha-glucosidase) |
| chr19_+_4153598 | 0.89 |
ENST00000078445.2
ENST00000252587.3 ENST00000595923.1 ENST00000602257.1 ENST00000602147.1 |
CREB3L3
|
cAMP responsive element binding protein 3-like 3 |
| chr10_-_33623310 | 0.88 |
ENST00000395995.1
ENST00000374823.5 ENST00000374821.5 ENST00000374816.3 |
NRP1
|
neuropilin 1 |
| chr6_-_33860521 | 0.88 |
ENST00000525746.1
ENST00000531046.1 |
LINC01016
|
long intergenic non-protein coding RNA 1016 |
| chr12_-_74686314 | 0.88 |
ENST00000551210.1
ENST00000515416.2 ENST00000549905.1 |
RP11-81H3.2
|
RP11-81H3.2 |
| chr13_-_38172863 | 0.88 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
| chr11_+_27015628 | 0.88 |
ENST00000318627.2
|
FIBIN
|
fin bud initiation factor homolog (zebrafish) |
| chr4_-_87028478 | 0.88 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
| chr19_-_14064114 | 0.87 |
ENST00000585607.1
ENST00000538517.2 ENST00000587458.1 ENST00000538371.2 |
PODNL1
|
podocan-like 1 |
| chr4_+_119809984 | 0.87 |
ENST00000307142.4
ENST00000448416.2 ENST00000429713.2 |
SYNPO2
|
synaptopodin 2 |
| chr3_-_123339418 | 0.86 |
ENST00000583087.1
|
MYLK
|
myosin light chain kinase |
| chr15_+_54901540 | 0.85 |
ENST00000539562.2
|
UNC13C
|
unc-13 homolog C (C. elegans) |
| chr4_-_34271356 | 0.84 |
ENST00000514877.1
|
RP11-548L20.1
|
RP11-548L20.1 |
| chr15_+_62853562 | 0.84 |
ENST00000561311.1
|
TLN2
|
talin 2 |
| chr20_-_50419055 | 0.83 |
ENST00000217086.4
|
SALL4
|
spalt-like transcription factor 4 |
| chr3_-_143567262 | 0.82 |
ENST00000474151.1
ENST00000316549.6 |
SLC9A9
|
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 |
| chr10_-_71169031 | 0.82 |
ENST00000373307.1
|
TACR2
|
tachykinin receptor 2 |
| chr2_-_183387064 | 0.81 |
ENST00000536095.1
ENST00000331935.6 ENST00000358139.2 ENST00000456212.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
| chr22_-_32766972 | 0.81 |
ENST00000382084.4
ENST00000382086.2 |
RFPL3S
|
RFPL3 antisense |
| chr8_-_42234745 | 0.81 |
ENST00000220812.2
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4 |
| chr18_-_3219847 | 0.81 |
ENST00000261606.7
|
MYOM1
|
myomesin 1 |
| chr12_-_15815626 | 0.81 |
ENST00000540613.1
|
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
| chr1_+_162336686 | 0.81 |
ENST00000420220.1
|
C1orf226
|
chromosome 1 open reading frame 226 |
| chr18_-_33709268 | 0.80 |
ENST00000269187.5
ENST00000590986.1 ENST00000440549.2 |
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6 |
| chr12_-_10978957 | 0.80 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
| chr19_-_7968427 | 0.79 |
ENST00000539278.1
|
AC010336.1
|
Uncharacterized protein |
| chr20_-_50418972 | 0.79 |
ENST00000395997.3
|
SALL4
|
spalt-like transcription factor 4 |
| chr19_+_58570605 | 0.79 |
ENST00000359978.6
ENST00000401053.4 ENST00000439855.2 ENST00000313434.5 ENST00000511556.1 ENST00000506786.1 |
ZNF135
|
zinc finger protein 135 |
| chr20_-_50418947 | 0.78 |
ENST00000371539.3
|
SALL4
|
spalt-like transcription factor 4 |
Network of associatons between targets according to the STRING database.
First level regulatory network of EN1_ESX1_GBX1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.2 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 1.5 | 4.4 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.8 | 2.5 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.8 | 10.4 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.8 | 2.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.8 | 3.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.6 | 1.9 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.6 | 8.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.6 | 1.7 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.4 | 10.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.4 | 2.6 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.4 | 1.7 | GO:0048789 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.4 | 3.5 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.4 | 1.2 | GO:1903717 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.4 | 1.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.4 | 1.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.4 | 1.4 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.3 | 5.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.3 | 1.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 | 2.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.3 | 1.6 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 | 1.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.3 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.3 | 1.8 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.3 | 3.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.3 | 3.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.2 | 0.5 | GO:0051795 | positive regulation of catagen(GO:0051795) |
| 0.2 | 3.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 0.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.2 | 1.4 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.2 | 2.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 1.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.2 | 0.9 | GO:1902573 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.2 | 4.2 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.2 | 0.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.2 | 0.5 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 | 0.5 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.2 | 0.5 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.2 | 0.9 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.2 | 1.2 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 0.9 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 0.5 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.2 | 1.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 | 0.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 0.2 | 0.5 | GO:0070781 | arginine biosynthetic process via ornithine(GO:0042450) response to biotin(GO:0070781) |
| 0.2 | 0.8 | GO:0035106 | negative regulation of luteinizing hormone secretion(GO:0033685) operant conditioning(GO:0035106) |
| 0.2 | 0.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.2 | 0.5 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.2 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 | 2.0 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.2 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 | 1.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.2 | 5.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.2 | 0.6 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.2 | 3.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.3 | GO:2001186 | negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.1 | 0.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 | 0.7 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.1 | 0.5 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 0.9 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.1 | 0.7 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.1 | 0.9 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 1.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 | 2.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 | 1.7 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.1 | 0.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.1 | 1.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 2.0 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.1 | 3.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 1.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.1 | 1.2 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.1 | 1.8 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 1.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.1 | 0.5 | GO:0061346 | cardiac right atrium morphogenesis(GO:0003213) chemoattraction of serotonergic neuron axon(GO:0036517) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.1 | 0.5 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 0.4 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.1 | 3.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 2.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 0.4 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.1 | 0.8 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.1 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.3 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 0.1 | 0.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 | 0.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 | 1.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 | 0.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 0.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 0.4 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 1.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 0.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 | 2.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.5 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.6 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.1 | 1.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 | 3.8 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 0.6 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.1 | 0.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 1.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.4 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 1.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.3 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 | 1.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.1 | 0.3 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.1 | 1.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.1 | 0.4 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 0.1 | 0.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.1 | 0.1 | GO:2000974 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.1 | 0.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.1 | 0.4 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.1 | 7.5 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 1.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 0.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 | 1.6 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 0.2 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.1 | 1.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.1 | 0.3 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
| 0.1 | 5.4 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 0.3 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 | 1.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.1 | 4.1 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.1 | 1.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 | 0.8 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 1.1 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.1 | 0.6 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.0 | 1.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 1.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 4.3 | GO:0008542 | visual learning(GO:0008542) |
| 0.0 | 0.7 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.0 | 0.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.0 | 0.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 | 2.0 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 0.1 | GO:2001027 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.0 | 2.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 1.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.0 | 2.9 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.0 | 2.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.0 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 8.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.0 | 0.8 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 0.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 1.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.0 | 0.2 | GO:0048631 | negative regulation of skeletal muscle cell proliferation(GO:0014859) regulation of skeletal muscle tissue growth(GO:0048631) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) negative regulation of satellite cell differentiation(GO:1902725) |
| 0.0 | 0.5 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.0 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 1.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.0 | 1.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 1.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.0 | 3.1 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 4.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 0.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.0 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.0 | 0.1 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.0 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 | 0.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.0 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.0 | 0.2 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.0 | 0.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.0 | 0.7 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.0 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.5 | GO:0043010 | camera-type eye development(GO:0043010) |
| 0.0 | 0.2 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.0 | 1.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 | 0.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 2.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.1 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.0 | 0.2 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.0 | 1.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.0 | 1.3 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.0 | 1.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.0 | 1.7 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.4 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) regulation of adipose tissue development(GO:1904177) |
| 0.0 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 0.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 1.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 | 0.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 1.3 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.0 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.0 | 1.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 1.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.0 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.0 | 1.4 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.0 | 0.7 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 1.1 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.0 | 0.1 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.0 | 1.4 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.4 | GO:0060348 | bone development(GO:0060348) |
| 0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 2.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 0.0 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.0 | 2.0 | GO:0006096 | glycolytic process(GO:0006096) |
| 0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.0 | 0.5 | GO:0071514 | genetic imprinting(GO:0071514) |
| 0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 | 1.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.0 | 0.4 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.0 | 0.0 | GO:0045399 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.2 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 9.8 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.5 | 1.9 | GO:0060187 | cell pole(GO:0060187) |
| 0.5 | 1.4 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 0.4 | 2.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.3 | 2.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.3 | 3.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.3 | 3.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.3 | 2.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.3 | 1.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.2 | 2.0 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 3.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 2.0 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.2 | 2.3 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 3.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 1.3 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 2.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 0.5 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.1 | 3.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 17.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 5.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 3.0 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 1.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 1.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 1.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.1 | 0.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 1.9 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 8.6 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 1.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.1 | 0.7 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.1 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 1.0 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.0 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.0 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.0 | 2.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 2.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.0 | 0.8 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.0 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.0 | 4.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 8.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.1 | GO:0035101 | FACT complex(GO:0035101) |
| 0.0 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.0 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 4.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.0 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.0 | 0.8 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 1.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
| 0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.0 | 0.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 9.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 0.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 0.1 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.0 | 0.7 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 3.1 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
| 0.0 | 6.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.4 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 5.0 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.3 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 1.9 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 0.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 1.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.6 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.0 | 0.9 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.0 | 0.3 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 1.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 5.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.8 | 3.0 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.5 | 3.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.5 | 1.6 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.5 | 1.6 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.5 | 3.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.5 | 3.5 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
| 0.5 | 2.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.4 | 1.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.4 | 2.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.4 | 3.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.3 | 1.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 3.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.3 | 2.6 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.3 | 1.2 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.3 | 1.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.2 | 0.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.2 | 2.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.2 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 1.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 0.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.2 | 4.2 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 0.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.2 | 1.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.2 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 3.2 | GO:0048185 | activin binding(GO:0048185) |
| 0.2 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 1.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 1.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.5 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.1 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 0.3 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
| 0.1 | 2.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 1.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.1 | 4.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.1 | 1.5 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.1 | 0.3 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.1 | 0.4 | GO:0019862 | IgA binding(GO:0019862) |
| 0.1 | 2.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 1.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.3 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.1 | 3.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.1 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 2.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 1.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.1 | 2.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 2.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 0.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 0.2 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.1 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.5 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.1 | 0.2 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.1 | 2.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 0.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 1.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.1 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 2.0 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 7.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 0.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.1 | 1.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 2.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.0 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.0 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 1.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.0 | 3.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.0 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 5.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.0 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.0 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.0 | 1.2 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.0 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.0 | 1.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 9.0 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.0 | 0.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 1.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.0 | 1.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 1.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.0 | 0.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.0 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 4.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.0 | 0.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.0 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 8.9 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.6 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.0 | 2.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.0 | 1.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.0 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.4 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 0.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 1.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.0 | 3.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.0 | GO:0004803 | transposase activity(GO:0004803) |
| 0.0 | 0.1 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.0 | 3.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 22.0 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 1.8 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 0.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 3.0 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 3.9 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
| 0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.0 | 2.2 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.0 | 0.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.0 | 2.3 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.0 | 1.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.0 | 0.7 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 2.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.0 | 0.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 1.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 5.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.0 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.0 | 0.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.0 | 0.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 13.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 4.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 6.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 3.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 4.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 4.6 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 1.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.0 | 2.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 3.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.0 | 2.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 3.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 3.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 9.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.9 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 1.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 6.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 4.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.9 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 1.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 10.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.4 | 5.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 6.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 2.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 2.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 4.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 1.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 7.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 2.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.1 | 1.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 4.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 1.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 1.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 2.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 1.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.0 | 0.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.0 | 1.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 1.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.0 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.0 | 0.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.0 | 3.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 1.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 2.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 1.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 1.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 2.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 1.1 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.0 | 0.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 1.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 1.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 2.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 1.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 0.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |